Europe High Content Screening Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Europe high content screening market is expected to reach USD 1,057,169.94 thousand by 2030 from USD 626,271.12 thousand in 2022, growing at a CAGR of 6.8% during the forecast period of 2023 to 2033.

Market Segmentation

Europe High content screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Others), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and rest of Europe) - Industry Trends and Forecast to 2030.

Overview of Europe High Content Screening Market Dynamics

Driver
Increasing drug discovery and development activities
Restraint
High cost associated with initial setup and maintenance
Opportunity
The growing number of Contract Research Organizations (CROS) providing HCS services

Market Players

The key market players operating in the global high content screening market are listed below:

BD
Merck KGaA
Corning Incorporated
Carl Zeiss AG
Sartorius AG
EVIDENT
Zifo RnD Solutions
Axxam S.p.A.
Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Yokogawa Electric Corporation
Sysmex Corporation
Genedata AG
Miltenyi Biotec

1 INTRODUCTION 27

1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW OF THE EUROPE HIGH CONTENT SCREENING MARKET 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29

2 MARKET SEGMENTATION 32

2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 PRODUCT TYPE LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42

3 EXECUTIVE SUMMARY 43

4 PREMIUM INSIGHTS 45

4.1 PESTEL ANALYSIS 46
4.2 PORTER'S FIVE FORCES MODEL 47

5 EUROPE HIGH CONTENT SCREENING MARKET: REGULATIONS 48

6 MARKET OVERVIEW, EUROPE HIGH CONTENT SCREENING MARKET 49

6.1 DRIVERS 51
- 6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 51
- 6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 51
- 6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 52
- 6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 53
6.2 RESTRAINTS 53
- 6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 53
- 6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 54
6.3 OPPORTUNITIES 55
- 6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 55
- 6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 55
- 6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 56
6.4 CHALLENGES 56
- 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 56
- 6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 57

7 EUROPE HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 58

7.1 OVERVIEW 59
7.2 INSTRUMENTS 62
- 7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 62
  - 7.2.1.1 FIXED 63
  - 7.2.1.2 MOBILE 63
- 7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 63
  - 7.2.2.1 FIXED 63
  - 7.2.2.2 MOBILE 63
- 7.2.3 FLOW CYTOMETRY 63
- 7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 63
- 7.2.5 MICROPLATE MOVER 64
- 7.2.6 OTHERS 64
7.3 SOFTWARE 64
7.4 CONSUMABLES 64
- 7.4.1 REAGENTS & ASSAY KITS 64
- 7.4.2 MICROPLATES 64
- 7.4.3 OTHERS 64
7.5 ACCESSORIES 65
7.6 SERVICES 65

8 EUROPE HIGH CONTENT SCREENING MARKET, BY APPLICATION 66

8.1 OVERVIEW 67
8.2 PRIMARY AND SECONDARY SCREENING 70
- 8.2.1 INSTRUMENTS 70
- 8.2.2 CONSUMABLES 70
- 8.2.3 ACCESSORIES 70
- 8.2.4 SERVICES 70
8.3 TARGET IDENTIFICATION AND VALIDATION 70
- 8.3.1 INSTRUMENTS 71
- 8.3.2 CONSUMABLES 71
- 8.3.3 ACCESSORIES 71
- 8.3.4 SERVICES 71
8.4 TOXICITY STUDIES 71
- 8.4.1 INSTRUMENTS 72
- 8.4.2 CONSUMABLES 72
- 8.4.3 ACCESSORIES 72
- 8.4.4 SERVICES 72
8.5 COMPOUND PROFILING 72
- 8.5.1 INSTRUMENTS 73
- 8.5.2 CONSUMABLES 73
- 8.5.3 ACCESSORIES 73
- 8.5.4 SERVICES 73
8.6 OTHER APPLICATIONS 73

9 EUROPE HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 74

9.1 OVERVIEW 75
9.2 MICROSCOPY 78
9.3 FLOW CYTOMETRY 78
9.4 IMMUNOHISTOCHEMISTRY 78
9.5 MASS SPECTROMETRY 78
9.6 ELISA 78
9.7 WESTERN BLOTTING 78
9.8 OTHERS 78
- 9.8.1 3D CELL CULTURE MODEL 79
  - 9.8.1.1 STEROIDS 79
  - 9.8.1.2 ORGANOIDS 79
  - 9.8.1.3 TISSUE ON A CHIP 79
- 9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 80
- 9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 80

10 EUROPE HIGH CONTENT SCREENING MARKET, BY END USER 81

10.1 OVERVIEW 82
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 85
- 10.2.1 INSTRUMENTS 85
- 10.2.2 CONSUMABLES 85
- 10.2.3 ACCESSORIES 85
- 10.2.4 SERVICES 85
10.3 CONTRACT RESEARCH ORGANIZATIONS 85
- 10.3.1 INSTRUMENTS 86
- 10.3.2 CONSUMABLES 86
- 10.3.3 ACCESSORIES 86
- 10.3.4 SERVICES 86
10.4 LABORATORIES 86
- 10.4.1 INSTRUMENTS 87
- 10.4.2 CONSUMABLES 87
- 10.4.3 ACCESSORIES 87
- 10.4.4 SERVICES 87
10.5 ACADEMIC AND GOVERNMENT INSTITUTES 87
- 10.5.1 INSTRUMENTS 88
- 10.5.2 CONSUMABLES 88
- 10.5.3 ACCESSORIES 88
- 10.5.4 SERVICES 88
10.6 OTHERS 88

11 EUROPE HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 89

11.1 OVERVIEW 90
11.2 DIRECT TENDERS 92
11.3 RETAIL SALES 92

12 EUROPE HIGH CONTENT SCREENING MARKET, BY REGION 93

12.1 OVERVIEW 94
- 12.1.1 GERMANY 99
- 12.1.2 FRANCE 106
- 12.1.3 U.K. 113
- 12.1.4 ITALY 120
- 12.1.5 SPAIN 126
- 12.1.6 RUSSIA 132
- 12.1.7 TURKEY 138
- 12.1.8 BELGIUM 144
- 12.1.9 DENMARK 150
- 12.1.10 NETHERLANDS 156
- 12.1.11 SWITZERLAND 162
- 12.1.12 SWEDEN 168
- 12.1.13 POLAND 174
- 12.1.14 NORWAY 180
- 12.1.15 FINLAND 186
- 12.1.16 REST OF EUROPE 193

13 EUROPE HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 194

13.1 COMPANY SHARE ANALYSIS: EUROPE 194

14 EUROPE CONTENT SCREENING MARKET, COMPANY PROFILES 195

14.1 THERMO FISHER SCIENTIFIC INC. (2022) 195
- 14.1.1 COMPANY SNAPSHOT 195
- 14.1.2 REVENUE ANALYSIS 195
- 14.1.3 PRODUCT PORTFOLIO 196
- 14.1.4 RECENT DEVELOPMENT 196
14.2 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 197
- 14.2.1 COMPANY SNAPSHOT 197
- 14.2.2 REVENUE ANALYSIS 197
- 14.2.3 PRODUCT PORTFOLIO 198
- 14.2.4 RECENT DEVELOPMENT 198
14.3 PERKINELMER INC. (2022) 199
- 14.3.1 COMPANY SNAPSHOT 199
- 14.3.2 REVENUE ANALYSIS 199
- 14.3.3 PRODUCT PORTFOLIO 200
- 14.3.4 RECENT DEVELOPMENTS 200
14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 201
- 14.4.1 COMPANY SNAPSHOT 201
- 14.4.2 REVENUE ANALYSIS 201
- 14.4.3 PRODUCT PORTFOLIO 202
- 14.4.4 RECENT DEVELOPMENT 202
14.5 BD 203
- 14.5.1 COMPANY SNAPSHOT 203
- 14.5.2 REVENUE ANALYSIS 203
- 14.5.3 PRODUCT PORTFOLIO 204
- 14.5.4 RECENT DEVELOPMENTS 204
14.6 MERCK KGAA 205
- 14.6.1 COMPANY SNAPSHOT 205
- 14.6.2 REVENUE ANALYSIS 205
- 14.6.3 PRODUCT PORTFOLIO 206
- 14.6.4 RECENT DEVELOPMENTS 206
14.7 AGILENT TECHNOLOGIES, INC. (2022) 207
- 14.7.1 COMPANY SNAPSHOT 207
- 14.7.2 REVENUE ANALYSIS 207
- 14.7.3 PRODUCT PORTFOLIO 208
- 14.7.4 RECENT DEVELOPMENT 208
14.8 ALIGNED GENETICS, INC. (2022) 209
- 14.8.1 COMPANY SNAPSHOT 209
- 14.8.2 REVENUE ANALYSIS 209
- 14.8.3 PRODUCT PORTFOLIO 210
- 14.8.4 RECENT DEVELOPMENT 210
14.9 AXXAM S.P.A 211
- 14.9.1 COMPANY SNAPSHOT 211
- 14.9.2 PRODUCT PORTFOLIO 211
- 14.9.3 RECENT DEVELOPMENT 211
14.10 BIO-RAD LABORATORIES, INC. (2022) 212
- 14.10.1 COMPANY SNAPSHOT 212
- 14.10.2 REVENUE ANALYSIS 212
- 14.10.3 PRODUCT PORTFOLIO 213
- 14.10.4 RECENT DEVELOPMENTS 213
14.11 CARL ZEISS AG 214
- 14.11.1 COMPANY SNAPSHOT 214
- 14.11.2 REVENUE ANALYSIS 214
- 14.11.3 PRODUCT PORTFOLIO 215
- 14.11.4 RECENT DEVELOPMENT 215
14.12 CORNING INCORPORATED 216
- 14.12.1 COMPANY SNAPSHOT 216
- 14.12.2 REVENUE ANALYSIS 216
- 14.12.3 PRODUCT PORTFOLIO 217
- 14.12.4 RECENT DEVELOPMENT 217
14.13 GENEDATA AG 218
- 14.13.1 COMPANY SNAPSHOT 218
- 14.13.2 PRODUCT PORTFOLIO 218
- 14.13.3 RECENT DEVELOPMENT 218
14.14 MILTENYI BIOTEC 219
- 14.14.1 COMPANY SNAPSHOT 219
- 14.14.2 PRODUCT PORTFOLIO 219
- 14.14.3 RECENT DEVELOPMENT 220
14.15 SARTORIUS AG 221
- 14.15.1 COMPANY SNAPSHOT 221
- 14.15.2 REVENUE ANALYSIS 221
- 14.15.3 PRODUCT PORTFOLIO 222
- 14.15.4 RECENT DEVELOPMENTS 222
14.16 SYSMEX CORPORATION 223
- 14.16.1 COMPANY SNAPSHOT 223
- 14.16.2 REVENUE ANALYSIS 223
- 14.16.3 PRODUCT PORTFOLIO 224
- 14.16.4 RECENT DEVELOPMENT 224
14.17 ZIFO RND SOLUTIONS 225
- 14.17.1 COMPANY SNAPSHOT 225
- 14.17.2 PRODUCT PORTFOLIO 225
- 14.17.3 RECENT DEVELOPMENTS 225

15 QUESTIONNAIRE 226

16 RELATED REPORTS 230

LIST OF TABLES

TABLE 1 EUROPE HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 61
TABLE 2 EUROPE INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 62
TABLE 3 EUROPE CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 62
TABLE 4 EUROPE HIGH-CONTENT AND SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
TABLE 5 EUROPE CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
TABLE 6 EUROPE HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 69
TABLE 7 EUROPE PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 70
TABLE 8 EUROPE TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 71
TABLE 9 EUROPE TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 72
TABLE 10 EUROPE COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 73
TABLE 11 EUROPE HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 77
TABLE 12 EUROPE OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 79
TABLE 13 EUROPE 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 79
TABLE 14 EUROPE HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 84
TABLE 15 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 16 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 86
TABLE 17 EUROPE LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 18 EUROPE ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 88
TABLE 19 EUROPE HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 92
TABLE 20 EUROPE HIGH CONTENT SCREENING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 98
TABLE 21 GERMANY HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 22 GERMANY INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 23 GERMANY CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 100
TABLE 24 GERMANY HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 100
TABLE 25 GERMANY CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 100
TABLE 26 GERMANY HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 101
TABLE 27 GERMANY PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 28 GERMANY TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 29 GERMANY TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
TABLE 30 GERMANY COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
TABLE 31 GERMANY HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 103
TABLE 32 GERMANY OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 103
TABLE 33 GERMANY 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 103
TABLE 34 GERMANY HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 104
TABLE 35 GERMANY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
TABLE 36 GERMANY CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
TABLE 37 GERMANY LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 38 GERMANY ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 39 GERMANY HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 105
TABLE 40 FRANCE HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 41 FRANCE INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 42 FRANCE CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 43 FRANCE HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 44 FRANCE CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 45 FRANCE HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 108
TABLE 46 FRANCE PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 47 FRANCE TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 48 FRANCE TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
TABLE 49 FRANCE COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
TABLE 50 FRANCE HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 110
TABLE 51 FRANCE OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 110
TABLE 52 FRANCE 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 110
TABLE 53 FRANCE HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 111
TABLE 54 FRANCE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
TABLE 55 FRANCE CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
TABLE 56 FRANCE LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 57 FRANCE ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 58 FRANCE HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 112
TABLE 59 U.K. HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 60 U.K. INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 61 U.K. CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 62 U.K. HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 63 U.K. CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 64 U.K. HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 114
TABLE 65 U.K. PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 66 U.K. TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 67 U.K. TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 68 U.K. COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 69 U.K. HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 116
TABLE 70 U.K. OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 116
TABLE 71 U.K. 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 117
TABLE 72 U.K. HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 117
TABLE 73 U.K. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
TABLE 74 U.K. CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 75 U.K. LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 76 U.K. ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 77 U.K. HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 119
TABLE 78 ITALY HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 79 ITALY INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 80 ITALY CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 81 ITALY HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 82 ITALY CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 83 ITALY HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
TABLE 84 ITALY PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 85 ITALY TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 86 ITALY TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 87 ITALY COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 88 ITALY HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 123
TABLE 89 ITALY OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 123
TABLE 90 ITALY 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 124
TABLE 91 ITALY HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
TABLE 92 ITALY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 93 ITALY CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 94 ITALY LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 95 ITALY ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 96 ITALY HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 125
TABLE 97 SPAIN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 98 SPAIN INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 99 SPAIN CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 100 SPAIN HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 101 SPAIN CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 102 SPAIN HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
TABLE 103 SPAIN PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 104 SPAIN TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 105 SPAIN TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 106 SPAIN COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 107 SPAIN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 129
TABLE 108 SPAIN OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 129
TABLE 109 SPAIN 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 129
TABLE 110 SPAIN HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 111 SPAIN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 112 SPAIN CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 113 SPAIN LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 114 SPAIN ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 115 SPAIN HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 131
TABLE 116 RUSSIA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 117 RUSSIA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 118 RUSSIA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 119 RUSSIA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 120 RUSSIA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 121 RUSSIA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 133
TABLE 122 RUSSIA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 123 RUSSIA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 124 RUSSIA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 125 RUSSIA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 126 RUSSIA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 135
TABLE 127 RUSSIA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 135
TABLE 128 RUSSIA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 135
TABLE 129 RUSSIA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
TABLE 130 RUSSIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 131 RUSSIA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 132 RUSSIA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
TABLE 133 RUSSIA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
TABLE 134 RUSSIA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 137
TABLE 135 TURKEY HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 136 TURKEY INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 137 TURKEY CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 138 TURKEY HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 139 TURKEY CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 140 TURKEY HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 140
TABLE 141 TURKEY PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 142 TURKEY TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 143 TURKEY TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 144 TURKEY COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 145 TURKEY HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 141
TABLE 146 TURKEY OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 142
TABLE 147 TURKEY 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 142
TABLE 148 TURKEY HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 149 TURKEY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 150 TURKEY CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 151 TURKEY LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 152 TURKEY ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 153 TURKEY HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 143
TABLE 154 BELGIUM HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 155 BELGIUM INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 156 BELGIUM CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 157 BELGIUM HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 158 BELGIUM CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 159 BELGIUM HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 145
TABLE 160 BELGIUM PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 161 BELGIUM TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 162 BELGIUM TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 163 BELGIUM COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 164 BELGIUM HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 147
TABLE 165 BELGIUM OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 147
TABLE 166 BELGIUM 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 147
TABLE 167 BELGIUM HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
TABLE 168 BELGIUM PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 169 BELGIUM CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 170 BELGIUM LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 171 BELGIUM ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149

TABLE 172 BELGIUM HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 149
TABLE 173 DENMARK HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 174 DENMARK INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 175 DENMARK CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 176 DENMARK HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 177 DENMARK CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 178 DENMARK HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 151
TABLE 179 DENMARK PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 180 DENMARK TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
TABLE 181 DENMARK TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
TABLE 182 DENMARK COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
TABLE 183 DENMARK HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 153
TABLE 184 DENMARK OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 153
TABLE 185 DENMARK 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 153
TABLE 186 DENMARK HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 154
TABLE 187 DENMARK PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 188 DENMARK CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 189 DENMARK LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 190 DENMARK ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 191 DENMARK HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 155
TABLE 192 NETHERLANDS HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 193 NETHERLANDS INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 194 NETHERLANDS CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 195 NETHERLANDS HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 196 NETHERLANDS CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 197 NETHERLANDS HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 158
TABLE 198 NETHERLANDS PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 199 NETHERLANDS TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 200 NETHERLANDS TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 201 NETHERLANDS COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 202 NETHERLANDS HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 159
TABLE 203 NETHERLANDS OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 160
TABLE 204 NETHERLANDS 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 160
TABLE 205 NETHERLANDS HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 206 NETHERLANDS PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 207 NETHERLANDS CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 208 NETHERLANDS LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 209 NETHERLANDS ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 210 NETHERLANDS HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 161
TABLE 211 SWITZERLAND HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 212 SWITZERLAND INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 213 SWITZERLAND CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 214 SWITZERLAND HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
TABLE 215 SWITZERLAND CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
TABLE 216 SWITZERLAND HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 163
TABLE 217 SWITZERLAND PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
TABLE 218 SWITZERLAND TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 219 SWITZERLAND TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 220 SWITZERLAND COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 221 SWITZERLAND HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 165
TABLE 222 SWITZERLAND OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 165
TABLE 223 SWITZERLAND 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 165
TABLE 224 SWITZERLAND HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 166
TABLE 225 SWITZERLAND PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 226 SWITZERLAND CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 227 SWITZERLAND LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 228 SWITZERLAND ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 229 SWITZERLAND HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 167
TABLE 230 SWEDEN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 231 SWEDEN INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 232 SWEDEN CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 233 SWEDEN HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 234 SWEDEN CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 235 SWEDEN HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 169
TABLE 236 SWEDEN PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 237 SWEDEN TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 238 SWEDEN TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 239 SWEDEN COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 240 SWEDEN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 171
TABLE 241 SWEDEN OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 171
TABLE 242 SWEDEN 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 171
TABLE 243 SWEDEN HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 172
TABLE 244 SWEDEN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 245 SWEDEN CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 246 SWEDEN LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
TABLE 247 SWEDEN ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
TABLE 248 SWEDEN HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 173
TABLE 249 POLAND HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 250 POLAND INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 251 POLAND CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 252 POLAND HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 253 POLAND CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 254 POLAND HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 175
TABLE 255 POLAND PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 256 POLAND TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 257 POLAND TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 258 POLAND COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
TABLE 259 POLAND HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 177
TABLE 260 POLAND OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 177
TABLE 261 POLAND 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 178
TABLE 262 POLAND HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 178
TABLE 263 POLAND PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
TABLE 264 POLAND CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 265 POLAND LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 266 POLAND ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 267 POLAND HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 179
TABLE 268 NORWAY HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 269 NORWAY INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 270 NORWAY CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 271 NORWAY HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 272 NORWAY CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 273 NORWAY HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 181
TABLE 274 NORWAY PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 275 NORWAY TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 276 NORWAY TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 277 NORWAY COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 278 NORWAY HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 183
TABLE 279 NORWAY OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 183
TABLE 280 NORWAY 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 183
TABLE 281 NORWAY HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 184
TABLE 282 NORWAY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 283 NORWAY CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 284 NORWAY LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 285 NORWAY ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 286 NORWAY HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 185
TABLE 287 FINLAND HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 288 FINLAND INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 289 FINLAND CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
TABLE 290 FINLAND HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
TABLE 291 FINLAND CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
TABLE 292 FINLAND HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 188
TABLE 293 FINLAND PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
TABLE 294 FINLAND TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
TABLE 295 FINLAND TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 296 FINLAND COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 297 FINLAND HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 190
TABLE 298 FINLAND OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 190
TABLE 299 FINLAND 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 190
TABLE 300 FINLAND HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 191
TABLE 301 FINLAND PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 302 FINLAND CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 303 FINLAND LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 304 FINLAND ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 305 FINLAND HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 192
TABLE 306 REST OF EUROPE HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193

LIST OF FIGURES

FIGURE 1 EUROPE HIGH CONTENT SCREENING MARKET: SEGMENTATION 32
FIGURE 2 EUROPE HIGH CONTENT SCREENING MARKET: DATA TRIANGULATION 34
FIGURE 3 EUROPE HIGH CONTENT SCREENING MARKET: DROC ANALYSIS 35
FIGURE 4 EUROPE HIGH CONTENT SCREENING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 36
FIGURE 5 EUROPE HIGH CONTENT SCREENING MARKET: COMPANY RESEARCH ANALYSIS 36
FIGURE 6 EUROPE HIGH CONTENT SCREENING MARKET: INTERVIEW DEMOGRAPHICS 38
FIGURE 7 EUROPE HIGH CONTENT SCREENING MARKET: DBMR MARKET POSITION GRID 39
FIGURE 8 EUROPE HIGH CONTENT SCREENING MARKET: MARKET APPLICATION COVERAGE GRID 40
FIGURE 9 EUROPE HIGH CONTENT SCREENING MARKET: VENDOR SHARE ANALYSIS 41
FIGURE 10 EUROPE HIGH CONTENT SCREENING MARKET: SEGMENTATION 44
FIGURE 11 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH-CONTENT SCREENING IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE HIGH CONTENT SCREENING MARKET IN THE FORECAST PERIOD 45
FIGURE 12 THE PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HIGH CONTENT SCREENING MARKET IN 2023 AND 2030 45
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE HIGH CONTENT SCREENING MARKET 50
FIGURE 14 EUROPE HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2022 59
FIGURE 15 EUROPE HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND) 60
FIGURE 16 EUROPE HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 60
FIGURE 17 EUROPE HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, LIFELINE CURVE 61
FIGURE 18 EUROPE HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2022 67
FIGURE 19 EUROPE HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 68
FIGURE 20 EUROPE HIGH CONTENT SCREENING MARKET: BY APPLICATION, CAGR (2023-2030) 68
FIGURE 21 EUROPE HIGH CONTENT SCREENING MARKET: BY APPLICATION, LIFELINE CURVE 69
FIGURE 22 EUROPE HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2022 75
FIGURE 23 EUROPE HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND) 76
FIGURE 24 EUROPE HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, CAGR (2023-2030) 76
FIGURE 25 EUROPE HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE 77
FIGURE 26 EUROPE HIGH CONTENT SCREENING MARKET: BY END USER, 2022 82
FIGURE 27 EUROPE HIGH CONTENT SCREENING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 83
FIGURE 28 EUROPE HIGH CONTENT SCREENING MARKET: BY END USER, CAGR (2023-2030) 83
FIGURE 29 EUROPE HIGH CONTENT SCREENING MARKET: BY END USER, LIFELINE CURVE 84
FIGURE 30 EUROPE HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2022 90
FIGURE 31 EUROPE HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 91
FIGURE 32 EUROPE HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 91
FIGURE 33 EUROPE HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 92
FIGURE 34 EUROPE HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 95
FIGURE 35 EUROPE HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 96
FIGURE 36 EUROPE HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 96
FIGURE 37 EUROPE HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 97
FIGURE 38 EUROPE HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 97
FIGURE 39 EUROPE HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 194